Mark L. Smythe
Chief Executive Officer en Infensa Bioscience Pty Ltd. .
Perfil
Mark L.
Smythe is the founder of Protagonist Therapeutics, Inc. which was founded in 2006.
He held the title of Vice President-Technology from 2013 to 2022.
Currently, he is the Chief Executive Officer at Infensa Bioscience Pty Ltd.
since 2022.
He previously worked at GSK Plc as a Principal.
Dr. Smythe obtained a doctorate from the University of Melbourne and an undergraduate degree from James Cook University.
Cargos activos de Mark L. Smythe
| Empresas | Cargo | Inicio |
|---|---|---|
| Infensa Bioscience Pty Ltd. | Chief Executive Officer | 01/05/2022 |
Antiguos cargos conocidos de Mark L. Smythe.
| Empresas | Cargo | Fin |
|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Founder | 01/05/2022 |
| GSK PLC | Corporate Officer/Principal | - |
Formación de Mark L. Smythe.
| University of Melbourne | Doctorate Degree |
| James Cook University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| GSK PLC | Health Technology |
| PROTAGONIST THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
| Infensa Bioscience Pty Ltd. |
- Bolsa de valores
- Insiders
- Mark L. Smythe
